1. Medtech Insight

IMDRF Offers Granular Playbook On ‘Regulatory Reliance’ Program Development And Implementation

 
• By Elizabeth Orr

International device regulatory group IMDRF has issued a new playbook on “regulatory reliance,” which allows regulators to make use of assessments performed by trusted regulatory partners. The document is the first to offer a detailed guide on developing and implementing these agreements.

The word "Playbook" beside a checklist.
(iQoncept/Shutterstock)

A draft playbook from the International Medical Device Regulators Forum (IMDRF) lays out a six-step approach to developing new reliance initiatives, marking a more granular approach to international reliance projects.

The Playbook for Medical Device Regulatory Reliance Programs, published on 31 March, is open for comments...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Medtech Insight

INBRAIN, Mayo Clinic To Test BCI With Standard Deep Brain Stimulation In Parkinson’s Patients

Barcelona-based INBRAIN Neuroelectronics is partnering with Mayo Clinic to test whether its graphene-based cortical brain computer interface can enhance standard DBS in Parkinson’s, aiming for more precise adaptive therapy and improved gait outcomes.

Launching A Product In Japan? Don’t Rush The Reimbursement Dossier, Expert Says

 
• By Elizabeth Orr

Launching a medical device in Japan requires a solid reimbursement strategy as patients can't pay out of pocket. Companies must build ties with experts and prepare a comprehensive reimbursement dossier. Japan's strict pricing and focus on clinical benefits make early planning essential for success.

Don’t Wait! Early Talks With Device Innovators Pay Off, Say Australia, Malaysia Regulators

 
• By Ashley Yeo

APACMed 2025 delegates heard how two global device regulators have shifted to a policy of early advice for innovators, with benefits for all industry stakeholders.

ShiraTronics Targets FDA Approval for Migraine Implant In 2027, Australian Review to Follow

 
• By Shubham Singh

The ShiraTronics Migraine Therapy System is a fully implantable neuromodulation platform purpose-built for head-based therapy. Unlike earlier off-label adaptations of spinal cord stimulators, it employs subcutaneous leads targeting the occipital and supraorbital nerves.

More from Compliance

Global Medtech Guidance Tracker: August 2025

 
• By Sabah Javed Peerzade

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. 60 documents have been posted on the tracker since its last update.

PathAI Expands AISight Dx Label With PCCP-Guided Addition Of Roche Scanners

 
• By Natasha Barrow

Roche’s scanners have been integrated with PathAI’s AISight Dx system. The system’s FDA-cleared PCCP allows new components to be validated and integrated without additional FDA clearance. Eric Walk, chief medical officer, hints at future biopharma companion diagnostic collaborations.

Warning Letters - August 2025

The US FDA posted nine device-related warning letters in August, covering clinical research labs, laser therapy, orthopedics and more.